Moxifloxacin: a respiratory fluoroquinolone
- 21 June 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 9 (10) , 1755-1772
Abstract
(2008). Moxifloxacin: a respiratory fluoroquinolone. Expert Opinion on Pharmacotherapy: Vol. 9, No. 10, pp. 1755-1772. doi: 10.1517/14656566.9.10.1755Keywords
This publication has 95 references indexed in Scilit:
- Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research DatabaseBMJ, 2007
- Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): Efficacy and Safety of Moxifloxacin Therapy versus That of Levofloxacin TherapyClinical Infectious Diseases, 2006
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005
- Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary DiseasePharmacoEconomics, 2005
- An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax, 2004
- Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adultsThe Journal of Laryngology & Otology, 2003
- Epidemiology of Chronic Obstructive Pulmonary Disease ExacerbationsClinical Pulmonary Medicine, 2002
- A Multinational, Multicentre, Non-Blinded, Randomized Study of Moxifloxacin Oral Tablets Compared with Co-Amoxiclav Oral Tablets in the Treatment of Acute Exacerbation of Chronic BronchitisJournal of International Medical Research, 2001
- Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitisEuropean Respiratory Journal, 2001
- Pharmacokinetics, Safety and Tolerability of Moxifloxacin, a Novel 8-Methoxyfluoroquinolone, after Repeated Oral AdministrationClinical Pharmacokinetics, 2001